Gastroenterology & Endoscopy最新文献

筛选
英文 中文
Efficacy and safety of EUS-guided cholecystolithotomy: A meta-analysis eus引导下胆囊取石术的疗效和安全性:一项荟萃分析
Gastroenterology & Endoscopy Pub Date : 2023-07-01 DOI: 10.1016/j.gande.2023.05.003
Qian Yue , Changqing Zhong , Xin Huang , Qiang Cai , Lianyong Li
{"title":"Efficacy and safety of EUS-guided cholecystolithotomy: A meta-analysis","authors":"Qian Yue ,&nbsp;Changqing Zhong ,&nbsp;Xin Huang ,&nbsp;Qiang Cai ,&nbsp;Lianyong Li","doi":"10.1016/j.gande.2023.05.003","DOIUrl":"https://doi.org/10.1016/j.gande.2023.05.003","url":null,"abstract":"<div><h3>Background</h3><p>The recurrence rate and readmission rate of patients with gallbladder stones and cholecystitis are high. Endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) is a new method for the treatment of cholecystitis in patients with high surgical risk. The acute symptoms can be relieved by drainage of bile, and cholecystolithotomy or polyp resection can be performed through a stent or fistula.</p></div><div><h3>Aims</h3><p>This article introduced the technique of EUS-guided cholecystolithotomy and conducted a meta-analysis evaluating its feasibility and safety.</p></div><div><h3>Methods</h3><p>Four electronic databases including SinoMed, CNKI, Wanfang Data, and PubMed were researched from inception to June 2022. Two researchers independently carried out literature screening and the data relevant to success rate and safety of per-oral cholecystoscopy were extracted for further meta-analysis by R Programming Language.</p></div><div><h3>Results</h3><p>A total of 7 studies with 129 patients were included in the present analysis. The results showed that the technical success rate of endoscopic ultrasonography-guided cholecystolithotomy was 97% [95%CI (92%-99%)], the clinical success rate was 93% [95%CI (87%–96%)]. The total adverse event rates were 34% [95% CI (14%–63%)]. Subgroup analysis of four major individual adverse events was fever 11.91% [95% CI (2.05%–46.62%)], peritonitis 2.33% [95% CI (0.75%–6.96%)], bleeding 4.37% [95% CI (0.72%–22.34%)], and abdominal pain 0.91% [95% CI (0.02%–26.38%)]. The adverse events were mild and recovered after conservative treatment.</p></div><div><h3>Conclusion</h3><p>EUS-guided cholecystolithotomy is a safe and alternative treatment modality for patients with symptomatic cholecystolithiasis, with acceptable procedure related complications. However, due to the limited data, further well-designed studies are warranted prior to confident adoption of the novel method into clinical practice.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 3","pages":"Pages 125-129"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49884737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential applications of ChatGPT in endoscopy: Opportunities and limitations ChatGPT在内窥镜检查中的潜在应用:机遇与局限
Gastroenterology & Endoscopy Pub Date : 2023-07-01 DOI: 10.1016/j.gande.2023.06.001
Weifeng Li , Jing Wang , Yan Yan , Peng Yuan , Changqi Cao , Shijie Li , Qi Wu
{"title":"Potential applications of ChatGPT in endoscopy: Opportunities and limitations","authors":"Weifeng Li ,&nbsp;Jing Wang ,&nbsp;Yan Yan ,&nbsp;Peng Yuan ,&nbsp;Changqi Cao ,&nbsp;Shijie Li ,&nbsp;Qi Wu","doi":"10.1016/j.gande.2023.06.001","DOIUrl":"https://doi.org/10.1016/j.gande.2023.06.001","url":null,"abstract":"<div><p>ChatGPT is an artificial intelligence model that has the potential to revolutionize the field of endoscopy. It can rapidly summarize medical records, assist with diagnosis, provide patient communication support, and even understand endoscopic images. However, there are limitations, including the risk of inaccurate or inappropriate responses, privacy and security issues, and the potential to limit doctors' thinking. Further research and improvements are needed to ensure ChatGPT's safe use in the medical field. Overall, the potential benefits of ChatGPT in endoscopy are vast, and it has the ability to greatly improve the efficiency of diagnosis and treatment.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 3","pages":"Pages 152-154"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49884824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The application of chatbot in gastroenterology nursing 聊天机器人在胃肠病学护理中的应用
Gastroenterology & Endoscopy Pub Date : 2023-07-01 DOI: 10.1016/j.gande.2023.07.003
Yang Zhao , Chao Gao , Lu Zhang , Xiaopei Gao , Zheng Zhang
{"title":"The application of chatbot in gastroenterology nursing","authors":"Yang Zhao ,&nbsp;Chao Gao ,&nbsp;Lu Zhang ,&nbsp;Xiaopei Gao ,&nbsp;Zheng Zhang","doi":"10.1016/j.gande.2023.07.003","DOIUrl":"https://doi.org/10.1016/j.gande.2023.07.003","url":null,"abstract":"<div><h3>Objective</h3><p>The advent of large language models has triggered a wave of technological advancements in the global AI dialogue system, which has been widely adopted in various fields including medical care. This research aims to investigate the potential of chatbots in the field of gastroenterology nursing.</p></div><div><h3>Methods</h3><p>Two nurses compiled and categorized 20 relevant questions related to gastroenterology nursing, grouping them into four modules. Two chatbot-based AI language models were selected to answer all the questions. The satisfaction levels and satisfaction rates for each module were analyzed to evaluate the performance of the two chatbots.</p></div><div><h3>Results</h3><p>Chatbot A received an overall satisfaction rate of 85% (with 9 very satisfied, 8 satisfied, and 3 dissatisfied responses), while chatbot B had a lower satisfaction rate of 45% (with 0 very satisfied, 9 satisfied, and 11 dissatisfied responses). The satisfaction rates for module 1 (pre-hospital care) were 60% for chatbot A and 20% for chatbot B. In module 2 (health education during hospitalization), chatbot A's satisfaction rate was 100%, while chatbot B's satisfaction was only 60%. For module 3 (continuing care after discharge), chatbot A's satisfaction rate was 100%, while chatbot B's was 40%. Finally, in module 4 (nursing management), chatbot A received an 80% satisfaction rate, compared to chatbot B's 60% satisfaction rate.</p></div><div><h3>Conclusion</h3><p>The performance of chatbot in terms of health education and nursing management for patients during hospitalization is acceptable; Further optimization is needed in terms of pre hospitalization nursing interventions and post discharge continuity care. The performance of different chatbots varies, and intelligent large models need to be tailored to the medical or nursing fields to better apply in the field of digestive disease care.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 3","pages":"Pages 136-138"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49884831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of chatbots on gastroenterology: Let's chat about the future 聊天机器人在胃肠病学中的作用:让我们谈谈未来
Gastroenterology & Endoscopy Pub Date : 2023-07-01 DOI: 10.1016/j.gande.2023.06.002
Lianyong Li
{"title":"Role of chatbots on gastroenterology: Let's chat about the future","authors":"Lianyong Li","doi":"10.1016/j.gande.2023.06.002","DOIUrl":"https://doi.org/10.1016/j.gande.2023.06.002","url":null,"abstract":"<div><p>New chatbot models, built on the transformer architecture and trained on large amounts of data, have the potential to transform healthcare, including gastroenterology. In this paper, we synthesized current literature reports on the roles of chatbots, and evaluated their potential applications in various areas such as clinical diagnosis and treatment plans, patient triage, scientific research, and academic writing. We believe that chatbots can improve efficiency and patient outcomes in these fields. However, it is important to acknowledge some challenges that need to be addressed, such as privacy concerns and emotional considerations. Overall, chatbots are expected to have a significant influence on gastroenterology and require more research to comprehensively examine their capabilities.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 3","pages":"Pages 144-149"},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49884826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022 中国胃食管反流病多学科诊治共识2022
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2023.01.001
Zhiwei Hu , Jimin Wu , Zhonggao Wang , The Consensus Committee , Members of the Expert Group of the Consensus (ordered alphabetically by the pinyin of surnames), Xinghua Bai , Yu Lan , Kefang Lai , Abudureyimu Kelimu , Feng Ji , Zhenling Ji , Diyu Huang , Zhiwei Hu , Xiaohua Hou , Jianyu Hao , Zhining Fan , Xiaoping Chen , Dong Chen , Shengliang Chen , Jinrang Li , Duowu Zou
{"title":"Chinese consensus on multidisciplinary diagnosis and treatment of gastroesophageal reflux disease 2022","authors":"Zhiwei Hu ,&nbsp;Jimin Wu ,&nbsp;Zhonggao Wang ,&nbsp;The Consensus Committee ,&nbsp;Members of the Expert Group of the Consensus (ordered alphabetically by the pinyin of surnames),&nbsp;Xinghua Bai ,&nbsp;Yu Lan ,&nbsp;Kefang Lai ,&nbsp;Abudureyimu Kelimu ,&nbsp;Feng Ji ,&nbsp;Zhenling Ji ,&nbsp;Diyu Huang ,&nbsp;Zhiwei Hu ,&nbsp;Xiaohua Hou ,&nbsp;Jianyu Hao ,&nbsp;Zhining Fan ,&nbsp;Xiaoping Chen ,&nbsp;Dong Chen ,&nbsp;Shengliang Chen ,&nbsp;Jinrang Li ,&nbsp;Duowu Zou","doi":"10.1016/j.gande.2023.01.001","DOIUrl":"https://doi.org/10.1016/j.gande.2023.01.001","url":null,"abstract":"","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 33-86"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49885378","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment 胰腺癌微环境中CC趋化因子治疗靶点和预后生物标志物的鉴定
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2022.11.006
Xinyuan Liu, Qi Zhang, Tao Mao, Congcong Min, Jing Guo, Cuiping Zhang, Zibin Tian, Xiaoyu Li
{"title":"Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment","authors":"Xinyuan Liu,&nbsp;Qi Zhang,&nbsp;Tao Mao,&nbsp;Congcong Min,&nbsp;Jing Guo,&nbsp;Cuiping Zhang,&nbsp;Zibin Tian,&nbsp;Xiaoyu Li","doi":"10.1016/j.gande.2022.11.006","DOIUrl":"https://doi.org/10.1016/j.gande.2022.11.006","url":null,"abstract":"<div><p>Pancreatic adenocarcinoma (PAAD), one of the most aggressive and lethal malignant tumors, is correlated with increased morbidity and mortality. CC chemokines can modulate the infiltration of immune cells and affect the clinical outcome of cancer patients. However, the therapeutic potential and prognostic value of CC chemokines in PAAD have not yet been elucidated. To do this, we comprehensively explore and analyze large amounts of data base on ONCOMINE, UALCAN, GEPIA2, LinkedOmics, Kaplan-Meier Plotter, cBioPortal, GeneMANIA, DAVID 6.8, TRRUST, TIMER, TISIDB, DGIdb, and TTD. We found the transcriptional levels of CCL5/7/13/15/18/19/20 in PAAD tissues were remarkably increased, whereas the transcriptional level of CCL17 was decreased. CCL20 expression had significantly been correlated with the tumor stage of PAAD patients. High expressions of CCL5, CCL7, CCL13, CCL18, and CCL20 were notably correlated with the prognosis of patients. Moreover, patients with CCL18 and CCL19 alterations showed a poor prognosis in both overall survival (OS) and disease-specific survival (DSS). Patients with CCL5 and CCL15 alterations also presented a poor prognosis in OS. The key transcription factors for CC chemokines are RELA and NF-κB1. The functions of the differentially expressed CC chemokines were mainly correlated the chemokine signaling pathway, cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, and so forth. We also discovered significant associations between the expression levels of CC chemokines and six infiltrating immune cells including, CD8<sup>+</sup> T cells, CD4<sup>+</sup> T cells, B cells, macrophages, neutrophils, and dendritic cells. The drug-gene interactions and related miRNAs of aberrant expression CC chemokines were also explored. Our study indicated the correlation between CC chemokines and PAAD and clarified the value of differentially expressed CC chemokines as potential therapeutic targets and prognostic markers for PAAD.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 91-101"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49885377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ischemic colitis after receipt of COVID-19 vaccine: Causative or coincidence? 接种COVID-19疫苗后缺血性结肠炎:原因还是巧合?
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2023.04.001
Xin Huang , Jihua Wu , Changqing Zhong
{"title":"Ischemic colitis after receipt of COVID-19 vaccine: Causative or coincidence?","authors":"Xin Huang ,&nbsp;Jihua Wu ,&nbsp;Changqing Zhong","doi":"10.1016/j.gande.2023.04.001","DOIUrl":"https://doi.org/10.1016/j.gande.2023.04.001","url":null,"abstract":"","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 118-119"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49860991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-induced liver injury: An overview and update 药物性肝损伤:综述与最新进展
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2022.11.005
Yujie Wang, Wen Xie
{"title":"Drug-induced liver injury: An overview and update","authors":"Yujie Wang,&nbsp;Wen Xie","doi":"10.1016/j.gande.2022.11.005","DOIUrl":"https://doi.org/10.1016/j.gande.2022.11.005","url":null,"abstract":"<div><p>Drug-induced liver injury (DILI) is a relatively rare but important adverse event for a variety of commonly used drugs, herbal and dietary supplements, illegal drugs and novel agents. The actual epidemiology of DILI is difficult to evaluate and varies between different countries. Many risk factors have been identified for DILI but the exact and detailed mechanisms of DILI still remain largely unknown. DILI has been typically classified as direct or idiosyncratic, but indirect injury has been recognized as the third type of DILI. It is difficult to predict and prevent DILI due to the lack of acute diagnosis tools. Many novel serum biomarkers have been identified for DILI and need further study in the clinic. For management, discontinuation of suspicious drugs is the first and important step. Effective drugs treatment is limited but novel drugs have been explored. Novel drugs, such as immune checkpoint inhibitors and monoclonal antibodies, have emerging as important causative agents of DILI. This paper reviewed the epidemiology, risk factors, pathogenesis, clinical presentation, causative agents, diagnosis and management of DILI.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 102-109"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49885375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prediction of esophageal varices in patients with hepatitis B-associated liver cirrhosis by non-invasive markers 用无创标志物预测乙型肝炎相关肝硬化患者食管静脉曲张
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2023.02.002
Lili Gao, Yijin Zhang, Xuesong Gao, Li Xu, Xuefei Duan
{"title":"Prediction of esophageal varices in patients with hepatitis B-associated liver cirrhosis by non-invasive markers","authors":"Lili Gao,&nbsp;Yijin Zhang,&nbsp;Xuesong Gao,&nbsp;Li Xu,&nbsp;Xuefei Duan","doi":"10.1016/j.gande.2023.02.002","DOIUrl":"https://doi.org/10.1016/j.gande.2023.02.002","url":null,"abstract":"<div><h3>Aims</h3><p>To assess the non-invasive markers for diagnosing and grading esophageal varices(EV) in hepatitis B-associated liver cirrhosis by non-invasive method.</p></div><div><h3>Methods</h3><p>A total of 209 treatment-naive patients with hepatitis B-associated liver cirrhosis were included in this study. These patients were divided into no EV, large grade EV and any grade EV groups according to electronic gastroscope (EGD) results. Blood tests, physical examination, and abdominal ultrasound scan (USS) were measured. The non-invasive indexes for predicting esophageal varices were screened, and non conditional logistic regression model was established. Performance was expressed as sensitivity, specificity, positive, and negative predictive values (PPV, NPV), accuracy, and area under the curve (AUC).</p></div><div><h3>Results</h3><p>In the 209 patients, 155 (74.2%) EV and 106(50.7%) large EV were found. There were significant differences in spleen-length (SL), portal vein diameter (PVD), platelet blood cell (PLT) and white blood cell (WBC) between patients with any grade or large and without EV by univariate analysis. The logistic regression model was Y=-2.083-0.011∗PLT+0.101∗PVD+0.013∗SL with any grade EV, the prediction formula is Y= ​0.427-0.013∗PLT -0.861∗WBC+0.008∗SL with large EV.</p></div><div><h3>Conclusions</h3><p>Spleen-length, portal vein diameter, platelet and white blood cell can predict esophageal varices and large esophageal varices in hepatitis B-associated liver cirrhosis.</p></div>","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 87-90"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49885376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative 病例报告:慢性丙型肝炎,抗HCV阳性,血清HCV RNA阴性
Gastroenterology & Endoscopy Pub Date : 2023-04-01 DOI: 10.1016/j.gande.2022.11.004
Huihui Lu , Wen Deng , Yao Lu , Lu Zhang , Yao Xie , Minghui Li
{"title":"Case report: Chronic hepatitis C with anti-HCV positive and serum HCV RNA negative","authors":"Huihui Lu ,&nbsp;Wen Deng ,&nbsp;Yao Lu ,&nbsp;Lu Zhang ,&nbsp;Yao Xie ,&nbsp;Minghui Li","doi":"10.1016/j.gande.2022.11.004","DOIUrl":"https://doi.org/10.1016/j.gande.2022.11.004","url":null,"abstract":"","PeriodicalId":100571,"journal":{"name":"Gastroenterology & Endoscopy","volume":"1 2","pages":"Pages 120-123"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49860257","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信